669 related articles for article (PubMed ID: 28772209)
1. Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies.
Patel S; Rauf A; Khan H; Abu-Izneid T
Biomed Pharmacother; 2017 Oct; 94():317-325. PubMed ID: 28772209
[TBL] [Abstract][Full Text] [Related]
2. [Renin-angiotensin-aldosterone system (RAAS) and its pharmacologic modulation].
Giestas A; Palma I; Ramos MH
Acta Med Port; 2010; 23(4):677-88. PubMed ID: 20687997
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible?
Emdin M; Fatini C; Mirizzi G; Poletti R; Borrelli C; Prontera C; Latini R; Passino C; Clerico A; Vergaro G
Clin Chim Acta; 2015 Mar; 443():85-93. PubMed ID: 25445411
[TBL] [Abstract][Full Text] [Related]
4. New approaches to blockade of the renin-angiotensin-aldosterone system: overview of regulation of the renin-angiotensin-aldosterone system.
Nishiyama A; Kim-Mitsuyama S
J Pharmacol Sci; 2010; 113(4):289-91. PubMed ID: 20675960
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
Rao MS
J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
[TBL] [Abstract][Full Text] [Related]
6. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
Weir MR; Rolfe M
Clin J Am Soc Nephrol; 2010 Mar; 5(3):531-48. PubMed ID: 20150448
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.
Humalda JK; Lambers Heerspink HJ; Kwakernaak AJ; Slagman MC; Waanders F; Vervloet MG; Ter Wee PM; Navis G; de Borst MH;
Am J Kidney Dis; 2015 Feb; 65(2):259-66. PubMed ID: 25278093
[TBL] [Abstract][Full Text] [Related]
8. [Regulatory mechanisms for the renin-angiotensin-aldosterone system].
Ichihara A
Nihon Rinsho; 2012 Sep; 70(9):1477-81. PubMed ID: 23012790
[TBL] [Abstract][Full Text] [Related]
9. The renin-angiotensin-aldosterone system and its therapeutic targets.
Mirabito Colafella KM; Bovée DM; Danser AHJ
Exp Eye Res; 2019 Sep; 186():107680. PubMed ID: 31129252
[TBL] [Abstract][Full Text] [Related]
10. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
Duprez DA
J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
[TBL] [Abstract][Full Text] [Related]
11. A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men.
Adamzik M; Frey UH; Bitzer K; Jakob H; Baba HA; Schmieder RE; Schneider MP; Heusch G; Peters J; Siffert W
Basic Res Cardiol; 2008 Nov; 103(6):598-610. PubMed ID: 18846354
[TBL] [Abstract][Full Text] [Related]
12. Chronobiology of the renin-angiotensin-aldosterone system in dogs: relation to blood pressure and renal physiology.
Mochel JP; Fink M; Peyrou M; Desevaux C; Deurinck M; Giraudel JM; Danhof M
Chronobiol Int; 2013 Nov; 30(9):1144-59. PubMed ID: 23931032
[TBL] [Abstract][Full Text] [Related]
13. The renin-angiotensin-aldosterone system in podocytes.
Wennmann DO; Hsu HH; Pavenstädt H
Semin Nephrol; 2012 Jul; 32(4):377-84. PubMed ID: 22958492
[TBL] [Abstract][Full Text] [Related]
14. Is the Renin-Angiotensin-Aldosterone System Good for the Kidney in Acute Settings?
Dudoignon E; Dépret F; Legrand M
Nephron; 2019; 143(3):179-183. PubMed ID: 30999307
[TBL] [Abstract][Full Text] [Related]
15. Salt feedback on the renin-angiotensin-aldosterone system.
Schweda F
Pflugers Arch; 2015 Mar; 467(3):565-76. PubMed ID: 25502115
[TBL] [Abstract][Full Text] [Related]
16. Emerging drugs which target the renin-angiotensin-aldosterone system.
Steckelings UM; Paulis L; Unger T; Bader M
Expert Opin Emerg Drugs; 2011 Dec; 16(4):619-30. PubMed ID: 21905943
[TBL] [Abstract][Full Text] [Related]
17. [Activity of renin-angiotensin-aldosterone system (RAAS) and vasopressin level in patients with primary pulmonary hypertension].
Martyniuk TV; Chazova IE; Masenko VP; Volkov VN; Belenkov IuN
Ter Arkh; 1998; 70(4):33-6. PubMed ID: 9612899
[TBL] [Abstract][Full Text] [Related]
18. Role of poly (ADP-ribose)-polymerase and its signaling pathway with renin-angiotensin aldosterone system in renal diseases.
Zhou TB; Jiang ZP
J Recept Signal Transduct Res; 2014 Jun; 34(3):143-8. PubMed ID: 24303937
[TBL] [Abstract][Full Text] [Related]
19. Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
Tylicki L; Rutkowski P; Renke M; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
Am J Kidney Dis; 2008 Sep; 52(3):486-93. PubMed ID: 18423812
[TBL] [Abstract][Full Text] [Related]
20. Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins.
Drapala A; Sikora M; Ufnal M
J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):250-8. PubMed ID: 25037529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
